Edward C Saltzman insider trades

Open-market stock purchases and sales by Edward C Saltzman, Director at Nurix Therapeutics, Inc, from SEC Form 4 filings since Sep 12, 2022.

Recent trades

DateStockTradeValue
May 15, 2026NRIX Nurix Therapeutics, IncBought (not open market)—

Companies traded

  • NRIX Nurix Therapeutics, Inc: other filings, last May 15, 2026

Get free alerts when Edward C Saltzman files a new trade →